This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Healthcare Global Enterprises
Healthcare Global Enterprises (HCG), headquartered in India, is a leading player in the oncology and healthcare sector. Established in 2001, HCG has made significant strides in providing comprehensive cancer care, with a network of hospitals and clinics across major operational regions in India and beyond. HCG is renowned for its advanced cancer treatment services, including radiation therapy, chemotherapy, and surgical oncology, distinguished by its commitment to personalised patient care and cutting-edge technology. The company has achieved notable milestones, such as being the first to introduce a dedicated cancer hospital in India, solidifying its position as a pioneer in the industry. With a focus on innovation and excellence, HCG continues to enhance its market position, recognised for its high standards of care and successful patient outcomes.
DitchCarbon Score
How does Healthcare Global Enterprises's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Healthcare Global Enterprises's score of 26 is lower than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Healthcare Global Enterprises's reported carbon emissions
In 2024, Healthcare Global Enterprises reported total carbon emissions of approximately 34,900,190 kg CO2e, comprising 981,240 kg CO2e from Scope 1 and 34,889,950 kg CO2e from Scope 2 emissions. This represents a significant increase in emissions compared to 2023, when the company recorded about 24,000,130 kg CO2e, with 2,929,130 kg CO2e from Scope 1 and 21,769,000 kg CO2e from Scope 2. Despite the increase in emissions, there are currently no publicly disclosed reduction targets or climate pledges from Healthcare Global Enterprises. The emissions data is cascaded from the parent company, CVC Capital Partners plc, indicating a corporate family relationship that influences their reporting and climate strategy. Healthcare Global Enterprises has not disclosed any Scope 3 emissions data, which typically includes indirect emissions from the supply chain and product use. The absence of reduction initiatives or specific climate commitments suggests that the company may be in the early stages of developing a comprehensive climate strategy. Overall, while the emissions figures highlight the company's operational impact, the lack of reduction targets indicates a potential area for improvement in their sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 2,929,130 | 000,000 |
| Scope 2 | 21,769,000 | 00,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Healthcare Global Enterprises is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
